â– PHYSIOLOGICAL CORE: The Gq-protein coupled receptor pathway is a membrane-bound signal transduction system that regulates intracellular calcium mobilization and protein kinase activation.
â– TRANSDUCTION DYNAMICS:
1. Receptor Activation: Ligand binding (e.g., Angiotensin II, TRH, GnRH) activates the Gq alpha subunit.
2. PLC Cleavage: Active alpha-q stimulates Phospholipase C (PLC), which cleaves membrane PIP2 into two key second messengers.
3. IP3 Calcium Release: IP3 diffuses through the cytosol to bind to ligand-gated calcium channels on the endoplasmic reticulum, releasing calcium into the cytoplasm.
4. DAG & PKC Activation: Simultaneously, DAG remains in the membrane, cooperating with mobilized calcium to activate Protein Kinase C to drive cellular operations.
â– THERAPEUTIC TARGETS & MANAGEMENT:
Primary pharmacological intervention aims to restore physiological homeostatic balance. This is achieved by either competitively blocking receptor sites, allosterically inhibiting enzymes, or supplementing missing metabolic products.
â– COMPENSATORY HORMONAL & VASCULAR FEEDBACK:
Acute systemic shifts trigger immediate neural and hormonal reflexes to preserve blood flow to vital organs like the brain and kidneys.
[HY-BOARD-1384]
🌟 Dynamic Clinical Key:
In vascular smooth muscle, Gq-linked alpha-1 adrenergic receptors are activated by norepinephrine. The resulting calcium mobilization activates myosin light chain kinase, causing smooth muscle contraction and driving systemic vasoconstriction. Absolute contraindications include pregnancy, renal insufficiency, or concurrent use of metabolic inhibitors. Carefully evaluate the underlying cause of high blood pressure before aggressively suppressing compensatory vasoconstriction.